Wall Street Biobeat

More »
Apr 1, 2010 (Vol. 30, No. 7)

IP Position Critical to Biotech Investment

Looming Battle over Gene Patenting Could Jeopardize Medical Advances

    Takeaways: The Case for Gene Patents

    • Gene patents are the foundation of the biotech industry and precluding them would halt forward progress.

    • The patent system promotes innovation and stimulates investment in R&D.

    • If there were no exclusive rights in the final product, there would be
      little incentive to invest time and money into developing it.

    • Without the incentives offered by the issuance of patents, the industry and, ultimately, patients would suffer.

Lisa A. Haile (lisa.haile@dlapiper.com) is a partner at DLA Piper and co-chair of the firm’s global life sciences sector group. Web: www.dlapiper.com/lisa_haile. Twitter: @dnajd.


Readers' Comments

  • Add a comment
  • Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.

Related Content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Myriad Genetics Trial: Your Thoughts?

Do you agree with the Supreme Court’s decision in the Myriad case?

Suggest a Poll